Trials / Unknown
UnknownNCT04657952
Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients
Sphenopalatine Ganglion Block With Adrenaline Additive for Post-Dural Puncture Headache in Orthopedic Patients: A Randomized Controlled Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the efficacy, onset and duration of analgesia of sphenopalatine ganglion bock (SPGB) using lidocaine 4% with adrenaline as a treatment of postoperative Post dural puncture headache (PDPH) of orthopedic patients after lower limbs surgeries.
Conditions
- Sphenopalatine Ganglion Block
- Adrenaline
- Post-Dural Puncture Headache
- Orthopedic
- Randomized Controlled Study
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Sphenopalatine Ganglion Block | Sphenopalatine Ganglion Block will be performed by a transnasal approach. Few drops of lidocaine 2% will be instilled into both anterior nares. Then a cotton-tipped applicator soaked in 4% lignocaine \& adrenaline (1 to 200000 will be passed through both the nares and the end of the applicator tip will be positioned just superior to the middle turbinate and anterior to the pterygopalatine fossa and sphenopalatine ganglion for 5 min with the patient in the supine position. |
| DRUG | Medical Treatment | Patients will receive paracetamol 1 gm 6 hours daily intravenously for a day. If adequate pain relief will not be achieved, intravenous diclofenac 75 mg twice daily will be added. |
Timeline
- Start date
- 2020-12-10
- Primary completion
- 2021-05-10
- Completion
- 2021-05-20
- First posted
- 2020-12-08
- Last updated
- 2020-12-08
Source: ClinicalTrials.gov record NCT04657952. Inclusion in this directory is not an endorsement.